New WHO Public Inspection Report (WHOPIR) published
IS
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Ritonavir (WHOAPI-398) manufactured by Laurus Labs Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification procedure.
Cipla’s paediatric ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: